Impact BioMedical Inc. (IBO) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | -464K | 99K | -613K | -694K | -981 | -1.81M | -1.74M | -896K | -482K | -433K | -911 | -971 | -172.15K | -480.6K | -450.43K | -1.71M | -765.03K | -1.12M | -739.6K | -9.23K |
| Operating CF Margin % | -6628.57% | 1414.29% | -3405.56% | -9914.29% | - | - | - | - | - | - | - | - | -40.19% | -1164.6% | - | -1305.13% | -207.26% | -257.69% | - | - |
| Operating CF Growth % | -47198.67% | 105.48% | 64.69% | - | - | - | - | -92176% | -179.99% | 9.9% | 99.8% | 99.94% | 77.5% | 56.94% | 39.1% | -18443.75% | -5732.32% | -1299.75% | -825.12% | 72.29% |
| Net Income | -2.29M | 15.82M | -1.47M | -14.35M | -1.82K | -38.98M | 5.74M | -882K | -998K | -1.26M | -1.58K | -1.46K | -486.6K | -792.86K | -841.96K | -6.55M | -1.17M | -1.04M | -1.73M | -23.16K |
| Depreciation & Amortization | 285K | 568.66K | 288K | 288K | 407 | 401.23K | 379.6K | 279K | 280K | 280K | 380 | 371 | 72.31K | 69.43K | 66.33K | 79.16K | 71.57K | 68.94K | 46.72K | 77 |
| Stock-Based Compensation | 0 | 12K | 1K | -27K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 25.7K | -2.6K | 97.58K | 121.95K | 40.08K | -47.11K | 788.62K | 0 |
| Deferred Taxes | 0 | -2.58M | 0 | 0 | 0 | 47.46K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 210K | 0 | 2.71M | 0 | 0 | 25 | 0 |
| Other Non-Cash Items | 1.44M | -14.26M | 530K | 13.39M | 278 | 37.32M | -7.66M | -230K | 230K | 0 | 217 | 128 | 17.32K | 27.32K | 0 | 2.63M | -25 | -85 | 160.48K | 0 |
| Working Capital Changes | 95K | 541K | 42K | 6K | 157 | -592.49K | -187.77K | -63K | 6K | 548K | 69 | -11 | 199.11K | 8.11K | 227.62K | -702.36K | 297K | -98.12K | -4.23K | 13.85K |
| Change in Receivables | 5K | 10K | -15K | 0 | 0 | 0 | 172.91K | 0 | 0 | 0 | 128 | -124 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7.16K |
| Change in Inventory | 0 | 3K | 1K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 27K | 607K | 22K | -61K | 0 | -870.04K | 20.26K | -37K | 191K | 356K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Investing | -1K | 1K | 1K | 0 | 0 | 0 | 1.35K | 1K | 0 | 1K | 0 | -15 | -42.74K | -210.79K | -143.24K | 606.25K | -83.91K | 11.86K | -2.62M | 0 |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -16 | -42.74K | -210.79K | -143.24K | -11.77K | -83.91K | 0 | 0 | 0 |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | 9.98% | 510.79% | - | 8.97% | 22.73% | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 618.01K | 0 | 0 | -2.67M | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | -1K | 1K | 1K | 0 | 0 | 0 | 1.35K | 1K | 0 | 1K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 42.93K | 0 |
| Cash from Financing | 482K | -109K | 0 | 0 | 0 | 844.16K | 5.34M | 895K | 483K | 232K | 1.18K | 988 | 375.93K | 179.71K | 571.3K | -121.89K | -271.85K | -10.99K | 7.41M | 2.87M |
| Debt Issued (Net) | 482K | -109K | 0 | 0 | 0 | 844.16K | 302.6K | 895K | 483K | 232K | 0 | 0 | - | - | - | - | - | - | - | - |
| Equity Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 5.03M | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | - | - | - |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.18K | 988 | 380K | 182.25K | 583.22K | -21.89K | -21.85K | -10.99K | 1.34M | 2.87M |
| Net Change in Cash | 17K | -9K | -612K | -694K | -977 | -962.08K | 3.6M | 0 | 1K | -200K | 269 | 0 | 161.05K | -511.67K | -22.37K | -1.23M | -1.12M | -1.12M | 4.05M | 2.86M |
| Free Cash Flow | -464K | 99K | -613K | -694K | -981 | -1.81M | -1.74M | -896K | -482K | -433K | -912 | -986 | -214.89K | -691.38K | -593.67K | -1.72M | -848.94K | -1.12M | -739.6K | -9.23K |
| FCF Margin % | -6628.57% | 1414.29% | -3405.56% | -9914.29% | - | - | - | - | - | - | - | - | -50.17% | -1675.39% | - | -1314.1% | -229.99% | -257.69% | - | - |
| FCF Growth % | -47198.67% | 105.48% | 64.69% | - | - | - | - | -90772.21% | -124.3% | 37.37% | 99.85% | 99.94% | 74.69% | 38.06% | 19.73% | -18571.19% | -6372.04% | -1299.75% | -825.12% | 72.29% |
| FCF per Share | -0.00 | 0.00 | -0.05 | -0.06 | -0.00 | -0.16 | -0.02 | -0.08 | -0.04 | -0.01 | -0.01 | -0.01 | -0.00 | -0.00 | -0.00 | -0.01 | -0.00 | -0.01 | -0.00 | -0.00 |
| FCF Conversion (FCF/Net Income) | 0.20x | 0.02x | 0.42x | 0.05x | 0.00x | 0.07x | -0.41x | 1.01x | 0.50x | 0.35x | 0.00x | 0.00x | 0.35x | 0.61x | 0.53x | 0.26x | 0.65x | 1.07x | 0.72x | 0.40x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | - | - | - |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | - | - | - |